Previous Article | Next Article 
Journal of Clinical Microbiology, December 2000, p. 4633-4636, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antimicrobial Resistance of Salmonella
Isolates from Swine
Wondwossen A.
Gebreyes,1
Peter R.
Davies,2
W. E. Morgan
Morrow,3
Julie A.
Funk,4 and
Craig
Altier1,*
Department of Microbiology, Pathology, and
Parasitology1 and Department of Farm
Animal Health and Resource Management,4 College
of Veterinary Medicine, and Department of Animal Science,
College of Agriculture and Life Sciences,3
North Carolina State University, Raleigh, North Carolina 27606, and
Institute of Veterinary, Animal, and Biomedical Sciences,
Massey University, Palmerston North, New Zealand2
Received 7 July 2000/Returned for modification 30 August
2000/Accepted 25 September 2000
 |
ABSTRACT |
We examined the antimicrobial resistance of 1,257 isolates of 30 serovars of Salmonella enterica subsp. enterica
isolated from swine. Serovars Typhimurium and Typhimurium var.
Copenhagen were widespread and were frequently multidrug resistant,
with distinct resistance to ampicillin, kanamycin, streptomycin,
sulfamethoxazole, and tetracycline and to ampicillin, chloramphenicol,
streptomycin, sulfamethoxazole, and tetracycline, respectively.
 |
TEXT |
Nontyphoidal salmonellosis is a
major food-borne disease worldwide and is estimated to be responsible
for the deaths of more than 500 people each year, with costs of $1.1
billion to $1.5 billion annually in the United States alone (6,
11). In recent years, antimicrobial-resistant
Salmonella strains have been isolated with increasing
frequency. This trend has obvious public health implications, since
multidrug resistance (MDR) limits therapeutic options for the
treatment of disease in humans and animals. In this report we
describe the antimicrobial resistance of Salmonella isolates
obtained from commercial swine companies.
Samples were collected in three independent studies performed in North
Carolina from 1997 through 1998. In Study 1, samples were obtained from
two commercial swine production companies that use all in-all out
(AIAO) management systems. We twice sampled feces from nine groups of
pigs from each company, once at the end of the nursery phase (when the
pigs were approximately 10 weeks of age) and again at finisher farms
(when the pigs were 26 to 27 weeks of age), on a total of three nursery
and nine finisher farms per company. From each group of 640 to 1,000 pigs, 96 fecal samples (weight, approximately 10 g each) were
collected from each rectum with a gloved hand at each sampling event.
Before the pigs were moved to finishing barns, 10 samples were
collected from the disinfected floors by dragging sterile gauze wetted
with buffered peptone water (Difco, Detroit, Mich.) over the floors. In
this study, a total of 3,456 fecal samples (96 samples each from 18 nursery and 18 finisher group visits) and 180 drag swab specimens were
collected. In the second study, two farms that use AIAO and two other
farms that use continuous-flow management were chosen. These farms were
visited once at the nursery stage and three times at the finishing
stage (when the pigs were at 15 and 22 weeks of age and at 48 h before
slaughter). At each visit, 1-g fecal samples were collected with
sterile swabs from the rectum of each of 60 identified pigs. Prior to
slaughter, samples were taken from the transport trucks both before the
pigs were loaded and after they were removed. At slaughter, 10 g of cecal tissue and contents and 10 g of mesenteric lymph node were collected. In this study, two replicate samplings were done, for a
total of 1,920 fecal samples, 480 cecal samples, and 480 lymph node
samples. In the third study, fecal samples were collected from 1,200 pigs from one farm at the nursery and finisher levels. The cecal
contents were collected at slaughter. In this study, 168 fecal and 165 cecal isolates were analyzed.
Isolation of Salmonella was done by conventional methods
(1, 4, 5). Briefly, the samples from studies 1 and 3 were preenriched with buffered peptone water (Becton Dickinson, Franklin Lake, N.J.), and those from study 2 were enriched in Hajna GN and
Tetrathionate broth (Difco). The samples in buffered peptone water and
Hajna GN were then incubated at 37°C for 24 h; samples in
Tetrathionate broth were incubated at 37°C for 48 h. The samples were
then transferred to Rappaport Vassilliadis medium (Difco) at 1:100
dilutions and were incubated at 42°C (studies 1 and 3) or 37°C
(study 2) for 24 h. All samples were then plated onto Bacto XLT-4
agar base (Difco), and the plates were incubated at 37°C for 24 h. Single colonies were tested for the appropriate reactions on triple
sugar iron agar (Difco) and urea agar (Difco). The serovars of the
Salmonella isolates were determined by the National
Veterinary Services Laboratories, Ames, Iowa.
We identified 1,257 Salmonella enterica subsp.
enterica isolates of 30 serovars. The predominant serovars
were Typhimurium var. Copenhagen (33.2%), Derby (24.2%),
Typhimurium (14.1%), Heidelberg (7.1%), and Infantis
(3.9%), together composing 82.5% of all isolates (Table
1). These predominant serovars were also
widespread among farms. Serovar Typhimurium var. Copenhagen was
isolated from 20 of the 29 farms (71.4%), followed by serovars Derby
(16 farms), Typhimurium (10 farms), Heidelberg (8 farms), and Infantis
(5 farms). Serovar Typhimurium var. Copenhagen was also common in all
of the sources that we cultured.
We next tested the susceptibilities of the 1,257 isolates to amikacin,
amoxicillin-clavulanic acid, ampicillin, cefotaxime, cephalothin,
chloramphenicol, ciprofloxacin, gentamicin, piperacillin, tetracycline,
and trimethoprim-sulfamethoxazole by MIC testing with the Vitek Jr.
automated system (Biomerieux, Hazelwood, Mo.). National Committee for
Clinical Laboratory Standards breakpoints were used (7). The
susceptibilities of selected isolates to sulfamethoxazole,
streptomycin, and kanamycin were determined by Kirby-Bauer disk
susceptibility testing on Mueller-Hinton plates by using conventional
techniques (8). Escherichia coli strains ATCC
25922 and ATCC 35218 and Pseudomonas aeruginosa ATCC 27853 were used for quality control purposes. Isolates for which MICs were
intermediate were considered susceptible for the purposes of this study
so as not to overstate the extent of resistance. In study 1 a
maximum of 15 isolates, chosen by random sampling, per serovar per
group of pigs was tested. All isolates from study 2 were tested. Among
the isolates from study 3 all isolates obtained from fecal samples were
tested, whereas a maximum of five isolates per serovar per slaughter
group were tested for isolates of cecal origin.
We found resistance to tetracycline to be common among these isolates,
with 84.2% of all isolates being resistant to tetracycline (Table
2). Isolates were commonly resistant to
-lactam antimicrobials as well: ampicillin (47.6%), piperacillin
(36.7%), and the combination of amoxicillin and clavulanic acid
(32%). Resistance to chloramphenicol, an antimicrobial not used in
veterinary medicine for more than a decade, was also prevalent among
these isolates (30.5%), suggesting a genetic linkage between
chloramphenicol resistance and resistance to other antimicrobials. We
found a low frequency of resistance to gentamicin, cephalothin, and
trimethoprim-sulfamethoxazole; fewer than 3% of isolates showed
resistance to any one of these antimicrobials. We found no resistance
to cefotaxime or amikacin. All isolates were also considered
susceptible to ciprofloxacin (MICs,
0.5 µg/ml).
We next examined the frequency of resistance among serovars to
determine whether resistance phenotypes were clustered within serovars
(Table 2). Resistance to tetracycline was the most widely distributed,
with at least 85% of isolates from the four most common serovars being
resistant to that antimicrobial. For the other antimicrobials, however,
only one or two of the serovars accounted for a great majority of the
resistant isolates. For example, 47.6% of all isolates were ampicillin
resistant, but serovars Typhimurium and Typhimurium var. Copenhagen
together constituted 92.6% (555 of 599) of all ampicillin-resistant
isolates. Similarly, 32% of all isolates were resistant to
amoxicillin-clavulanic acid, but 83.9% of serovar Typhimurium var.
Copenhagen isolates were resistant (comprising 87% of all the
amoxicillin-clavulanic acid-resistant isolates). Also, chloramphenicol
resistance was predominantly found among serovar Typhimurium var.
Copenhagen isolates; 30.5% of all isolates were resistant to this
antimicrobial, but 87% of these were serovar Typhimurium var.
Copenhagen (83.9% of all serovar Typhimurium var. Copenhagen
isolates). Among antimicrobials to which resistance was less common,
differences among serovars were also seen; only 3% of all isolates
were gentamicin resistant, but 79% of these (30 of 38) were serovar
Derby. These results show that the most frequently isolated serovars
were also most likely to express antimicrobial resistance factors.
We next determined the frequency of MDR, identified the common patterns
of resistance, and determined whether these patterns could be
correlated with specific serovars. We found that 625 (49.7%) of our
isolates were resistant to two or more of the antimicrobials tested
(Table 3). However, the majority of these
isolates were serovars Typhimurium and Typhimurium var. Copenhagen.
Among the serovar Typhimurium isolates, 96% were MDR, and a total of
80% were resistant to ampicillin and tetracycline, alone or in
combination with resistance to piperacillin or amoxicillin-clavulanic
acid. The majority of serovar Typhimurium var. Copenhagen isolates
(76.5%) had a single antimicrobial resistance pattern: ampicillin,
amoxicillin-clavulanic acid, chloramphenicol, piperacillin, and
tetracycline. This pattern was detected in isolates derived from 20 of
the 29 farms, suggesting that these MDR isolates were widespread among
the farms studied. Similarly, MDR serovar Typhimurium isolates were
obtained from 10 farms. We also found that serovar Typhimurium and
Typhimurium var. Copenhagen isolates had the greatest diversity of
resistance patterns, with 16 different patterns each. Thus, 89% of our
MDR isolates were either serovar Typhimurium or serovar Copenhagen, and
these were some of the most widespread.
Salmonella of the MDR DT104 phage type have a characteristic
pentadrug resistance pattern, with resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (AmCmStSuTe) (10). To determine whether phage type DT104
might be present among our isolates, we screened those that were
resistant to at least ampicillin, chloramphenicol, and tetracycline
(AmCmTe) for resistance to sulfamethoxazole and streptomycin. As a
further test, we examined isolates for susceptibility to kanamycin, an antimicrobial to which resistance has been reported among
Salmonella strains but not one to which DT104 strains are
commonly resistant. We tested 99 AmCmTe serovar Typhimurium var.
Copenhagen isolates, as well as 6 serovar Typhimurium and 14 serovar
Derby isolates, and found that 98 of 99 serovar Typhimurium var.
Copenhagen isolates, all serovar Typhimurium isolates, and 11 of 14 serovar Derby isolates also exhibited resistance to streptomycin and
sulfamethoxazole. We next tested representatives of the AmCmStSuTe
isolates for the presence of the resistance alleles found in DT104
isolates using multiplex PCR (3). DT104 carries its five
resistance factors on two adjacent integrons, harboring
aadA2, cmlA, and tetA-tetR (which
encode streptomycin, chloramphenicol, and tetracycline resistance,
respectively) and expressing ampicillin resistance by means of
blaPSE-1 (2). As is common for this
class of integron, these also encode sulfonamide resistance
(9). DNAs were extracted from selected isolates with a
DNAeasy kit (Qiagen, Valencia, Calif.), and approximately 100 ng of
template DNA was used for each reaction. Multiplex PCRs contained
primers for blaPSE-1, which encodes ampicillin resistance, and primers for physically linked cmlA and
tetR genes, which encode chloramphenicol and tetracycline
resistances, respectively, as well as primers for the
Salmonella-specific genes sipB and sipC. Isolates with the blaPSE-1 (150 bp) and the cmlA-tetR (280 bp) amplicons were tentatively
identified as phage type DT104 strains. We also examined isolates for
the presence of a second
-lactamase gene
(blaTEM) in a separate PCR (3). We
found that all of the serovar Typhimurium var. Copenhagen isolates with
the AmCmStSuTe resistance pattern that we tested (32 of 32 isolates derived from 14 farms) showed the pattern commonly seen in phage type
DT104 isolates (Table 4). Interestingly,
all of these isolates were also resistant to amoxicillin-clavulanic
acid, a characteristic found among only 24.5% of ampicillin-resistant
isolates of all other serovars. In contrast, of the six serovar
Typhimurium isolates with the AmCmStSuTe resistance pattern, only one
showed the presence of the resistance-encoding alleles commonly
found in phage type DT104 isolates. The single serovar Derby
isolate with this resistance pattern also did not have the
resistance-encoding alleles of DT104 isolates, showing that the
AmCmStSuTe resistance pattern can be expressed by types other than
DT104.
We also examined MDR isolates with patterns that included resistance to
kanamycin. We found a number of isolates with resistance to the
combination of ampicillin, kanamycin, streptomycin, sulfamethoxazole, and tetracycline. This pattern was the predominant pentadrug resistance pattern among the serovar Typhimurium isolates tested and was second
only to the AmCmStSuTe pattern among the pentadrug-resistant serovar
Typhimurium var. Copenhagen isolates. Of the 100 isolates for which
data are presented in Table 4, 51 had this pattern, with 22 being
serovar Typhimurium var. Copenhagen isolates and 29 being serovar
Typhimurium isolates. All of these isolates were also shown to encode
ampicillin resistance by means of the blaTEM gene rather than the blaPSE-1 gene of phage type
DT104 isolates. We also found 10 serovar Derby isolates that were
resistant to these five antimicrobials but that were additionally
resistant to chloramphenicol and gentamicin (Table 4). These isolates
were derived from one farm but were collected at three different times from the same group of pigs. The presence of these MDR patterns shows that MDR strains other than phage type DT104 strains exist among
the most common Salmonella serovars in commercial
swine herds.
 |
ACKNOWLEDGMENTS |
This work was supported by the U.S. Department of Agriculture
(grant 97-35201-4479 to P.D.), the National Pork Producers Council (grants 98-222 and 99-114 to P.R.D. and C.A.), and the North Carolina Pork Producers Council (grant 1999-1525 to C.A. and P.R.D.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: College of
Veterinary Medicine, North Carolina State University, 4700 Hillsborough St., Raleigh, NC 27606. Phone: (919) 513-6274. Fax: (919)
513-6455. E-mail: craig_altier{at}ncsu.edu.
 |
REFERENCES |
| 1.
|
Bager, F., and J. Petersen.
1991.
Sensitivity and specificity of different methods for the isolation of Salmonella from pigs.
Acta Vet. Scand.
32:473-481[Medline].
|
| 2.
|
Briggs, C. E., and P. M. Fratamico.
1999.
Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104.
Antimicrob. Agents Chemother.
43:846-849[Abstract/Free Full Text].
|
| 3.
|
Carlson, S. A.,
L. F. Bolton,
C. E. Briggs,
H. S. Hurd,
V. K. Sharma,
P. J. Fedorka-Cray, and B. D. Jones.
1999.
Detection of multiresistant Salmonella typhimurium DT104 using multiplex and fluorogenic PCR.
Mol. Cell. Probes
13:213-222[CrossRef][Medline].
|
| 4.
|
Davies, P. R.,
F. G. E. M. Bovee,
J. A. Funk,
F. T. Jones,
W. E. M. Morrow, and J. Deen.
1998.
Isolation of Salmonella serotypes from feces of pigs raised in a multiple-site production system.
J. Am. Vet. Med. Assoc.
212:1925-1929[Medline].
|
| 5.
|
Fedorka-Cray, P. J.,
D. A. Dargatz,
L. A. Thomas, and J. T. Gay.
1998.
Survey of Salmonella serotypes in feedlot cattle.
J. Food. Prot.
61:525-530[Medline].
|
| 6.
|
Mead, P. S.,
L. Slutsker,
V. Dietz,
L. F. McCaig,
J. S. Bresee,
C. Shapiro,
P. M. Griffin, and R. V. Tauxe.
1999.
Food-related illness and death in the United States.
Emerg. Infect. Dis.
5:607-625[Medline].
|
| 7.
|
National Committee for Clinical Laboratory Standards.
1991.
Interpretive standards of three categories of susceptibility for organisms other than Haemophilus and Neisseria gonorrhoeae.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 8.
|
National Committee for Clinical Laboratory Standards.
2000.
Performance standards for antimicrobial disc susceptibility tests; approved standard, 7th ed., M2-A7.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 9.
|
Stokes, H. W., and R. M. Hall.
1989.
A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions-integrons.
Mol. Microbiol.
3:1669-1683[Medline].
|
| 10.
|
Threlfall, E. J.,
J. A Frost,
L. R. Ward, and B. Rowe.
1996.
Increasing spectrum of resistance in multiresistant Salmonella typhimurium.
Lancet
347:1053-1054[Medline].
|
| 11.
|
Wesley, I., and M. Rasmussen.
1995.
Food-borne disease: control of Salmonella contamination in foods of animal origin, p. 83-85.
In
National Forum on Animal Production Food Safety. U.S. Department of Agriculture, College Park, Md.
|
Journal of Clinical Microbiology, December 2000, p. 4633-4636, Vol. 38, No. 12
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dorr, P. M., Tadesse, D. A., Zewde, B. M., Fry, P., Thakur, S., Gebreyes, W. A.
(2009). Longitudinal Study of Salmonella Dispersion and the Role of Environmental Contamination in Commercial Swine Production Systems. Appl. Environ. Microbiol.
75: 1478-1486
[Abstract]
[Full Text]
-
Foley, S. L., Lynne, A. M.
(2008). Food animal-associated Salmonella challenges: Pathogenicity and antimicrobial resistance. J ANIM SCI
86: E173-E187
[Abstract]
[Full Text]
-
Huang, Y., Leming, C. L., Suyemoto, M., Altier, C.
(2007). Genome-Wide Screen of Salmonella Genes Expressed during Infection in Pigs, Using In Vivo Expression Technology. Appl. Environ. Microbiol.
73: 7522-7530
[Abstract]
[Full Text]
-
Gebreyes, W. A., Thakur, S., Davies, P. R., Funk, J. A., Altier, C.
(2004). Trends in antimicrobial resistance, phage types and integrons among Salmonella serotypes from pigs, 1997-2000. J Antimicrob Chemother
53: 997-1003
[Abstract]
[Full Text]
-
Gebreyes, W. A., Altier, C.
(2002). Molecular Characterization of Multidrug-Resistant Salmonella enterica subsp. enterica Serovar Typhimurium Isolates from Swine. J. Clin. Microbiol.
40: 2813-2822
[Abstract]
[Full Text]